{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T04:10:28Z","timestamp":1742271028510,"version":"3.40.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s12149-024-02002-7","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T19:12:59Z","timestamp":1733166779000},"page":"315-322","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictive value of 18F-fluorodeoxyglucose uptake for axillary lymph node metastasis in operable breast cancer: impact of molecular subtypes"],"prefix":"10.1007","volume":"39","author":[{"given":"Chae Hong","family":"Lim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihyoun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo Bin","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,2]]},"reference":[{"issue":"3","key":"2002_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"2002_CR2","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1097\/01.SLA.0000065289.06765.71","volume":"237","author":"SW Beenken","year":"2003","unstructured":"Beenken SW, Urist MM, Zhang Y, Desmond R, Krontiras H, Medina H, et al. Axillary lymph node status, but not tumor size, predicts locoregional recurrence and overall survival after mastectomy for breast cancer. Ann Surg. 2003;237(5):732\u20139.","journal-title":"Ann Surg"},{"issue":"2","key":"2002_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4048\/jbc.2012.15.2.211","volume":"15","author":"A Oz","year":"2012","unstructured":"Oz A, Demirkazik FB, Akpinar MG, Soygur I, Baykal A, Onder SC, et al. Efficiency of ultrasound and ultrasound-guided fine needle aspiration cytology in preoperative assessment of axillary lymph node metastases in breast cancer. J Breast Cancer. 2012;15(2):211.","journal-title":"J Breast Cancer"},{"key":"2002_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2193-1801-2-350","volume":"2","author":"A Stachs","year":"2013","unstructured":"Stachs A, G\u00f6de K, Hartmann S, Stengel B, Nierling U, Dieterich M, et al. Accuracy of axillary ultrasound in preoperative nodal staging of breast cancer-size of metastases as limiting factor. Springerplus. 2013;2:1\u20139.","journal-title":"Springerplus"},{"key":"2002_CR5","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1007\/s00259-024-06696-9","volume":"51","author":"SC Vaz","year":"2024","unstructured":"Vaz SC, Woll JPP, Cardoso F, Groheux D, Cook GJ, Ulaner GA, et al. Joint EANM-SNMMI guideline on the role of 2-[18F] FDG PET\/CT in no special type breast cancer. Eur J Nucl Med Mol Imaging. 2024;51:2706\u201332.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"2002_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ejso.2011.01.003","volume":"37","author":"K Cooper","year":"2011","unstructured":"Cooper K, Harnan S, Meng Y, Ward S, Fitzgerald P, Papaioannou D, et al. Positron emission tomography (PET) for assessment of axillary lymph node status in early breast cancer: a systematic review and meta-analysis. Eur J Surg Oncol. 2011;37(3):187\u201398.","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"2002_CR7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.crad.2016.12.001","volume":"72","author":"X Liang","year":"2017","unstructured":"Liang X, Yu J, Wen B, Xie J, Cai Q, Yang Q. MRI and FDG-PET\/CT based assessment of axillary lymph node metastasis in early breast cancer: a meta-analysis. Clin Radiol. 2017;72(4):295\u2013301.","journal-title":"Clin Radiol"},{"issue":"8","key":"2002_CR8","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1001\/archsurg.141.8.783","volume":"141","author":"A Chung","year":"2006","unstructured":"Chung A, Liou D, Karlan S, Waxman A, Fujimoto K, Hagiike M, et al. Preoperative FDG-PET for axillary metastases in patients with breast cancer. Arch Surg. 2006;141(8):783\u20139.","journal-title":"Arch Surg"},{"key":"2002_CR9","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1007\/s12149-013-0720-x","volume":"27","author":"JW Seok","year":"2013","unstructured":"Seok JW, Kim Y, An Y-S, Kim BS. The clinical value of tumor FDG uptake for predicting axillary lymph node metastasis in breast cancer with clinically negative axillary lymph nodes. Ann Nucl Med. 2013;27:546\u201353.","journal-title":"Ann Nucl Med"},{"issue":"4","key":"2002_CR10","doi-asserted-by":"publisher","first-page":"e249","DOI":"10.1097\/RLU.0b013e3182a75477","volume":"39","author":"J Park","year":"2014","unstructured":"Park J, Byun BH, Noh WC, Lee SS, Kim H-A, Kim E-K, et al. Lymph node to primary tumor SUV ratio by 18F-FDG PET\/CT and the prediction of axillary lymph node metastases in breast cancer. Clin Nucl Med. 2014;39(4):e249\u201353.","journal-title":"Clin Nucl Med"},{"key":"2002_CR11","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s00259-010-1640-9","volume":"38","author":"D Groheux","year":"2011","unstructured":"Groheux D, Giacchetti S, Moretti J-L, Porcher R, Espi\u00e9 M, Lehmann-Che J, et al. Correlation of high 18 F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer. Eur J Nucl Med Mol Imaging. 2011;38:426\u201335.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2002_CR12","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.breast.2015.07.008","volume":"24","author":"A Prat","year":"2015","unstructured":"Prat A, Pineda E, Adamo B, Galv\u00e1n P, Fern\u00e1ndez A, Gaba L, et al. Clinical implications of the intrinsic molecular subtypes of breast cancer. Breast. 2015;24:S26\u201335.","journal-title":"Breast"},{"issue":"1","key":"2002_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13550-023-00953-y","volume":"13","author":"CM de Mooij","year":"2023","unstructured":"de Mooij CM, Ploumen RA, Nelemans PJ, Mottaghy FM, Smidt ML, van Nijnatten TJ. The influence of receptor expression and clinical subtypes on baseline [18F] FDG uptake in breast cancer: systematic review and meta-analysis. EJNMMI Res. 2023;13(1):5.","journal-title":"EJNMMI Res"},{"issue":"8","key":"2002_CR14","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.neo.2015.08.005","volume":"17","author":"RV Sim\u00f5es","year":"2015","unstructured":"Sim\u00f5es RV, Serganova IS, Kruchevsky N, Leftin A, Shestov AA, Thaler HT, et al. Metabolic plasticity of metastatic breast cancer cells: adaptation to changes in the microenvironment. Neoplasia. 2015;17(8):671\u201384.","journal-title":"Neoplasia"},{"issue":"3","key":"2002_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s13139-024-00843-8","volume":"58","author":"JR Young","year":"2024","unstructured":"Young JR, Ressler JA, Mortimer JE, Schmolze D, Fitzgibbons M, Chen BT. Association Between 18F-FDG PET Activity and HER2 Status in Breast Cancer Brain Metastases. Nucl Med Mol Imaging. 2024;58(3):113\u20139.","journal-title":"Nucl Med Mol Imaging"},{"key":"2002_CR16","doi-asserted-by":"crossref","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988:837\u201345.","DOI":"10.2307\/2531595"},{"issue":"9","key":"2002_CR17","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.clon.2019.05.021","volume":"31","author":"A Gandhi","year":"2019","unstructured":"Gandhi A, Coles C, Makris A, Provenzano E, Goyal A, Maxwell A, et al. Axillary surgery following neoadjuvant chemotherapy\u2013multidisciplinary guidance from the association of breast surgery, faculty of clinical oncology of the royal college of radiologists, UK breast cancer group, national coordinating committee for breast pathology and British society of breast radiology. Clin Oncol. 2019;31(9):664\u20138.","journal-title":"Clin Oncol"},{"issue":"12","key":"2002_CR18","doi-asserted-by":"publisher","first-page":"6639","DOI":"10.21873\/anticanres.13031","volume":"38","author":"P Orsaria","year":"2018","unstructured":"Orsaria P, Chiaravalloti A, Caredda E, Marchese PV, Titka B, Anemona L, et al. Evaluation of the usefulness of FDG-PET\/CT for nodal staging of breast cancer. Anticancer Res. 2018;38(12):6639\u201352.","journal-title":"Anticancer Res"},{"key":"2002_CR19","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s13244-010-0062-3","volume":"2","author":"NM Long","year":"2011","unstructured":"Long NM, Smith CS. Causes and imaging features of false positives and false negatives on 18F-PET\/CT in oncologic imaging. Insights Imaging. 2011;2:679\u201398.","journal-title":"Insights Imaging"},{"issue":"5","key":"2002_CR20","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s12094-019-02187-8","volume":"22","author":"Z Wu","year":"2020","unstructured":"Wu Z, Wu J, Zhao Q, Fu S, Jin J. Emerging roles of aerobic glycolysis in breast cancer. Clin Transl Oncol. 2020;22(5):631\u201346.","journal-title":"Clin Transl Oncol"},{"issue":"2","key":"2002_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/cells8020089","volume":"8","author":"N Gandhi","year":"2019","unstructured":"Gandhi N, Das GM. Metabolic reprogramming in breast cancer and its therapeutic implications. Cells. 2019;8(2):89.","journal-title":"Cells"},{"key":"2002_CR22","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s00259-002-0880-8","volume":"29","author":"A Buck","year":"2002","unstructured":"Buck A, Schirrmeister H, K\u00fchn T, Shen C, Kalker T, Kotzerke J, et al. FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters. Eur J Nucl Med Mol Imaging. 2002;29:1317\u201323.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"2002_CR23","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.1097\/RLU.0000000000002926","volume":"45","author":"CH Lim","year":"2020","unstructured":"Lim CH, Park Y-J, Shin M, Cho YS, Choi JY, Lee K-H, et al. Tumor SUVs on 18F-FDG PET\/CT and aggressive pathological features in esophageal squamous cell carcinoma. Clin Nucl Med. 2020;45(3):e128\u201333.","journal-title":"Clin Nucl Med"},{"issue":"2","key":"2002_CR24","doi-asserted-by":"publisher","first-page":"310","DOI":"10.2214\/AJR.10.4923","volume":"195","author":"MC Adams","year":"2010","unstructured":"Adams MC, Turkington TG, Wilson JM, Wong TZ. A systematic review of the factors affecting accuracy of SUV measurements. AJR Am J Roentgenol. 2010;195(2):310\u201320.","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"2002_CR25","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s12149-021-01709-1","volume":"36","author":"G Akamatsu","year":"2022","unstructured":"Akamatsu G, Shimada N, Matsumoto K, Daisaki H, Suzuki K, Watabe H, et al. New standards for phantom image quality and SUV harmonization range for multicenter oncology PET studies. Ann Nucl Med. 2022;36(2):144\u201361.","journal-title":"Ann Nucl Med"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-024-02002-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-024-02002-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-024-02002-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T11:07:39Z","timestamp":1742209659000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-024-02002-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,2]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["2002"],"URL":"https:\/\/doi.org\/10.1007\/s12149-024-02002-7","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"type":"print","value":"0914-7187"},{"type":"electronic","value":"1864-6433"}],"subject":[],"published":{"date-parts":[[2024,12,2]]},"assertion":[{"value":"26 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Board (IRB) and Ethic Committee of the Soonchunhyang University Seoul Hospital (#2024\u201306-011). Written informed consent was waived by the IRB of the Soonchunhyang University Seoul Hospital due to retrospective design.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}